sacituzumab govitecan April 12, 2017 sacituzumab govitecan Trade Name Orphan Indication Pancreatic cancer USA Market Approval USA USA Designation Date 2014-05-29 00:00:00 Sponsor Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950
